Vedanta Biosciences

Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. Vedanta Biosciences’ proprietary approach leverages foundational discoveries in the field of mucosal immunology to generate safe and potent treatments that restore intestinal homeostasis acting via mechanisms that are orthogonal to all existing drug classes. By modulating the microbiome with this class of drugs, we have the opportunity to treat a range of autoimmune and inflammatory diseases in potentially new ways and impact the lives of patients.
Company Growth (employees)
Type
Private
HQ
Cambridge, US
Founded
2010
Size (employees)
25 (est)+5%
Vedanta Biosciences was founded in 2010 and is headquartered in Cambridge, US

Vedanta Biosciences Office Locations

Vedanta Biosciences has office in Cambridge
Cambridge, US

Vedanta Biosciences Metrics

Vedanta Biosciences Summary

Founding Date

2010

Total Funding

$50 m

Latest funding size

$50 m

Time since last funding

10 months

Investors

We estimate that Vedanta Biosciences's latest funding round in June 2016 was $50 m. In total, Vedanta Biosciences has raised $50 m

Vedanta Biosciences Online Presence

Vedanta Biosciences Company Life

You may also be interested in